15 Nov 2022 Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON Member news
25 Oct 2022 Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON) Member news
12 Oct 2022 Mithra announces positive preclinical data demonstrating Estetrol’s efficacy in wound healing Member news
29 Sep 2022 Indigo Diabetes announces first participant enrolled in the SHINE clinical trial Member news
31 Aug 2022 reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration Member news
01 Aug 2022 Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial Member news
19 Jul 2022 Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR Member news
05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
28 Jun 2022 MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis Member news
10 May 2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
